A pilot study in north London in which a network of GP practices proactively contacted their patients to suggest statins found higher takeup levels. This was one of several studies at BHIVA to find ...

Two more people appear to be free of HIV after stem cell transplants for cancer treatment, according to a pair of posters presented at the Conference on Retroviruses and Opportunistic Infections (CROI ...

📢 With heavy hearts, we announce the proposed closure of our beloved charity, NAM aidsmap, this month. After 37 years of pioneering health journalism, community engagement, and empowerment through ...

It’s rare in any branch of medicine that a trial of a new drug can report 100% efficacy, and a first in HIV science. But that’s what happened on Friday, when Gilead Sciences announced that no HIV ...

In the same session, Dr Jenell Stewart of the Hennepin Healthcare Research Institute in Minneapolis, US argued that event-driven PrEP is demonstrably as effective as daily PrEP for gay men and trans ...

A once-weekly oral regimen can keep HIV suppressed as well as daily pills, according to study results presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2024). In a ...

Viral load results are also important for other aspects of patient care, but there are no clear data showing the clinical relevance of results below 200 copies/ml. One exception is that a viral load ...

“State health department websites serve as a free and trusted resource for health professionals and community members to access health information,” write researchers from George Washington University ...

BHIVA recommends that people aged 40 and over should be offered a statin irrespective of lipid levels or estimated cardiovascular risk. People with HIV aged 40 and over with an estimated 10-year risk ...

Significant numbers of people with well-controlled HIV in Amsterdam report symptoms of post-traumatic stress disorder, Kevin Moody of the University of Amsterdam told the 19th European AIDS Conference ...

An HIV vaccine candidate has proved it can guide B-cells, the part of the immune system that makes antibodies, into being able to produce broadly neutralising antibodies (bnAbs) with the ability to ...

But injectable HIV treatment could have a future in the global south, particularly when other long-acting products are developed, experts said at the 12th International AIDS Society Conference on HIV ...